NCT06898892 Comparison of Sonographic and MRI Weight Estimation in Fetuses with Suspected Macrosomia
| NCT ID | NCT06898892 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Western Galilee Hospital-Nahariya |
| Condition | Accuracy of Sonographic Vs MRI Fetal Weight Estimation |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-02-13 |
| Primary Completion | 2027-02-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-02-13 with a primary completion date of 2027-02-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the accuracy of sonographic vs. magnetic resonance fetal weight estimation in suspected fetal macrosomia in term pregnancy. Pregnant patient at term with suspected macrosomia will participate and undergo both sonographic and magnetic resonance fetal weight estimations and the actual birthweight will be recorded and compared with the fetal weight estimations
Eligibility Criteria
Inclusion Criteria: singleton pregnancy at term, suspected fetal macrosomia, Exclusion Criteria: * fetal anomaly multiple pregnancy PROM
Contact & Investigator
Amal shahin
PRINCIPAL INVESTIGATOR
Galilee Medical Center
Frequently Asked Questions
Who can join the NCT06898892 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Accuracy of Sonographic Vs MRI Fetal Weight Estimation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06898892 currently recruiting?
Yes, NCT06898892 is actively recruiting participants. Contact the research team at mayaw@gmc.gov.il for enrollment information.
Where is the NCT06898892 trial being conducted?
This trial is being conducted at Nahariya, Israel.
Who is sponsoring the NCT06898892 clinical trial?
NCT06898892 is sponsored by Western Galilee Hospital-Nahariya. The principal investigator is Amal shahin at Galilee Medical Center. The trial plans to enroll 80 participants.